Eagle Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Eagle Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-371,061	Closed	-$52M	–	645
2018 Q4	$52M	Buy	371,061 +20,864	+6%	+$3.17M	0.33%	123
2018 Q3	$59.8M	Buy	350,197 +291,278	+494%	+$48.9M	0.29%	143
2018 Q2	$10.2M	Buy	+58,919	New	+$8.85M	0.06%	323

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Eagle Asset Management's LOXO Position: Q1 2019 in Review

Eagle Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 371,061 shares — an estimated $52M sold.

Eagle Asset Management first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $59.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Eagle Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Eagle Asset Management sold 371,061 Loxo Oncology, Inc shares in Q1 2019, an estimated $52M.
Eagle Asset Management first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Eagle Asset Management's Loxo Oncology, Inc position peaked at $59.8M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Eagle Asset Management's 13F filing for Q1 2019, filed 1 May 2019.